Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia

被引:325
作者
Gasche, Y
Copin, JC
Sugawara, T
Fujimura, M
Chan, PH
机构
[1] Stanford Univ, Sch Med, Dept Neurosurg, Neurosurg Labs, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Neurosci Program, Stanford, CA 94305 USA
[4] Univ Hosp Geneva, Div Med, Lab Neurocrit Care Med, Geneva, Switzerland
[5] Univ Hosp Geneva, Div Surg Crit Care Med, Lab Neurocrit Care Med, Geneva, Switzerland
关键词
blood-brain barrier; metalloproteinases; oxidative stress; stroke; vasogenic edema;
D O I
10.1097/00004647-200112000-00003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oxidative stress generated during stroke is a critical event leading to blood-brain barrier (BBB) disruption with secondary vasogenic edema and hemorrhagic transformation of infarcted brain tissue, restricting the benefit of thrombolytic reperfusion. In this study, the authors demonstrate that ischemia-reperfusion-induced BBB disruption in mice deficient in copper/zinc-superoxide dismutase (SOD1) was reduced by 88% (P < 0.0001) and 73% (P < 0.01), respectively, after 3 and 7 hours of reperfusion occurring after I hour of ischemia by the inhibition of matrix metalloproteinases. Accordingly, the authors show that local metalloproteinase-generated proteolytic imbalance is more intense in ischemic regions of SOD1 mice than in wild-type litter mates. Moreover, active in situ proteolysis is, for the first time, demonstrated in ischemic leaking capillaries that produce reactive oxygen species. By showing that oxidative stress mediates BBB disruption through metalloproteinase activation in experimental ischemic stroke, this study provides a new target for future therapeutic strategies to prevent BBB disruption and potentially reperfusion-triggered intracerebral hemorrhage.
引用
收藏
页码:1393 / 1400
页数:8
相关论文
共 42 条
[1]   Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats [J].
Asahi, M ;
Asahi, K ;
Wang, XY ;
Lo, EH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2000, 20 (03) :452-457
[2]   Protection against blood-brain barrier disruption in focal cerebral ischemia by the type IV phosphodiesterase inhibitor BBB022: a quantitative study [J].
Belayev, L ;
Busto, R ;
Ikeda, M ;
Rubin, LL ;
Kajiwara, A ;
Morgan, L ;
Ginsberg, MD .
BRAIN RESEARCH, 1998, 787 (02) :277-285
[3]   Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical [J].
Benov, L ;
Sztejnberg, L ;
Fridovich, I .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 25 (07) :826-831
[4]  
Bindokas VP, 1996, J NEUROSCI, V16, P1324
[5]  
CHAN PH, 1994, BRAIN PATHOL, V4, P59
[6]  
CHAN PH, 1996, ADV NEUROL, V71, P241
[7]  
Christman JW, 2000, BRAIN PATHOL, V10, P153
[8]   The rtPA (Alteplase) 0-to 6-hour acute stroke trial, part A (A0276g) - Results of a double-blind, placebo-controlled, multicenter study [J].
Clark, WM ;
Albers, GW ;
Madden, KP ;
Hamilton, S .
STROKE, 2000, 31 (04) :811-816
[9]   THE NEURONAL MICROENVIRONMENT - A COMPARATIVE VIEW [J].
CSERR, HF ;
BUNDGAARD, M .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 481 :1-6
[10]   BRAIN EDEMA [J].
FISHMAN, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (14) :706-711